Agendia logo

Agendia

MammaPrint® + BluePrint® provides you with actionable insights throughout your patient’s breast cancer journey.

209 employees · est. 2003 · Irvine, United States

VS
OncoDNA logo

OncoDNA

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases

52 employees · est. 2014 · Belgium

Agendia is the older company (2003 vs 2014); Agendia is the larger of the two.

Side-by-Side Comparison

Agendia OncoDNA
Founded
2003 older 2014
Headquarters
Irvine, United States Belgium
Employees
209 larger 52
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care
Funding Stage
Private Equity Series C
Total Funding
$176.05M $35.38M
Funding Rounds
9 3
Services
Genomic Testing Platforms, Molecular Subtyping, Data Analysis for Treatment Planning, Clinical Trial Support OncoDEEP Kit, OncoSELECT Kit, OncoXPLORE Kit, Clinical Testing, Precision Enrollment, Clinical Data Intelligence (OncoCDI), Automated Library Preparation, OncoKDM Software, Project Care
Target Customers
Healthcare Providers, Medical Institutions, Breast Cancer Patients, Patient Advocacy Partners, Research Institutions Oncology Professionals, Laboratory Professionals, Pharma Companies, Healthcare Institutions, Biopharma Companies, Researchers
Taxonomy
Precision Oncology, Genomic Profiling, Molecular Subtyping, Cancer Recurrence Assay, Clinical Evidence, Real World Evidence, Treatment Guidelines, Next-Generation Diagnostics, Personalized Treatment, Breast Cancer, Genomic Testing, Medical Research, Digital Treatment Tools, Clinical Decision Support, Biopsy Analysis Genomics, Precision Medicine, Theranostics, Cancer Treatment, Genetic Diseases, Biomarker Testing, NGS Services, Clinical Decision Support, Digital Healthcare, Molecular Diagnostics, Oncology, DNA Sequencing, Bioinformatics, Medical Diagnostics
Website
agendia.com oncodna.com
Agendia logo

About Agendia

Agendia is a precision oncology company headquartered in Irvine, California, committed to providing patients with early stage breast cancer and their physicians the information they need to make the best treatment decisions. The company currently offers two commercially-available genomic profiling t...

OncoDNA logo

About OncoDNA

OncoDNA, founded in 2012 in Belgium, is a prominent player in the Biotechnology and Health Care industries. Specializing in precision medicine, this genomic and theranostic company focuses on enhancing cancer and genetic disease treatments. Their slogan, "Genomic and theranostic company specializing...

We will tell you when either one moves

BounceWatch watches Agendia and OncoDNA for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Agendia and OncoDNA — by email.

Frequently Asked Questions

Agendia — MammaPrint® + BluePrint® provides you with actionable insights throughout your patient’s breast cancer journey.. OncoDNA — Genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Agendia has raised $176.05M while OncoDNA has raised $35.38M.
Agendia and OncoDNA operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Agendia with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Agendia on 7 Feb 2025, and OncoDNA on 11 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy